Luptakova Katarina

Xilio Therapeutics, Inc. · CHIEF MEDICAL OFFICER

Luptakova Katarina is listed in filings as CHIEF MEDICAL OFFICER at Xilio Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 5, 2026, including 15 public disclosures. Recent filings connect the profile to Xilio Therapeutics, Inc. (XLO). The current snapshot covers public activity from Jan 3, 2025 to Jan 5, 2026. Reported amounts are shown as $380.0K to $428.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.